146 related articles for article (PubMed ID: 10102798)
1. Monophosphoryl lipid A, a derivative of bacterial lipopolysaccharide, fails to induce B1-receptor-dependent responses to (des-Arg9)-bradykinin in the rabbit in vivo.
Mazenot C; Ribuot C; Demenge P; Godin-Ribuot D
Immunopharmacology; 1999 Feb; 41(2):165-8. PubMed ID: 10102798
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.
Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D
Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755
[TBL] [Abstract][Full Text] [Related]
3. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
6. B1 kinin receptor activity in pigs is associated with pre-existing infection.
Siebeck M; Schorr M; Spannagl E; Lehner M; Fritz H; Cheronis JC; Whalley ET
Immunopharmacology; 1998 Jul; 40(1):49-55. PubMed ID: 9776478
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.
Audet R; Rioux F; Drapeau G; Marceau F
J Pharmacol Exp Ther; 1997 Jan; 280(1):6-15. PubMed ID: 8996175
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
Drapeau G; deBlois D; Marceau F
J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
[TBL] [Abstract][Full Text] [Related]
9. Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs.
Nakhostine N; Ribuot C; Lamontagne D; Nadeau R; Couture R
Br J Pharmacol; 1993 Sep; 110(1):71-6. PubMed ID: 8220916
[TBL] [Abstract][Full Text] [Related]
10. Characterization of des-Arg9-bradykinin-induced contraction in guinea-pig gallbladder in vitro.
Cabrini DA; Calixto JB
Eur J Pharmacol; 1997 Jul; 331(1):31-8. PubMed ID: 9274927
[TBL] [Abstract][Full Text] [Related]
11. Kinin B1 receptor-mediated motor responses in normal or inflamed rat urinary bladder in vivo.
Lecci A; Meini S; Tramontana M; Giuliani S; Criscuoli M; Maggi CA
Regul Pept; 1999 Mar; 80(1-2):41-7. PubMed ID: 10235633
[TBL] [Abstract][Full Text] [Related]
12. Endothelial kinin B(1)-receptors are induced by myocardial ischaemia-reperfusion in the rabbit.
Mazenot C; Loufrani L; Henrion D; Ribuot C; Muller-Esterl W; Godin-Ribuot D
J Physiol; 2001 Jan; 530(Pt 1):69-78. PubMed ID: 11136859
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production.
Galizzi JP; Bodinier MC; Chapelain B; Ly SM; Coussy L; Giraud S; Neliat G; Jean T
Br J Pharmacol; 1994 Oct; 113(2):389-94. PubMed ID: 7834189
[TBL] [Abstract][Full Text] [Related]
14. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.
Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F
Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
Campos MM; Souza GE; Calixto JB
Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
[TBL] [Abstract][Full Text] [Related]
16. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
[TBL] [Abstract][Full Text] [Related]
17. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor.
Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC
Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006
[TBL] [Abstract][Full Text] [Related]
18. Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1beta and TNFalpha.
Campos MM; Souza GE; Calixto JB
Peptides; 1998; 19(7):1269-76. PubMed ID: 9786178
[TBL] [Abstract][Full Text] [Related]
19. Endogenous B1 receptor mediated hypotension produced by contact system activation in the presence of endotoxemia.
Schmid A; Eich-Rathfelder S; Whalley ET; Cheronis JC; Scheuber HP; Fritz H; Siebeck M
Immunopharmacology; 1998 Aug; 40(2):131-7. PubMed ID: 9826027
[TBL] [Abstract][Full Text] [Related]
20. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
